Indicated for: schizophrenia; bipolar disorder
Route of administration: injectable
Substance: aripiprazole (antipsychotic)
ATC: N05AX12 (Nervous system | Antipsychotics | Other antipsychotics)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
This medicine may increase blood sugar.
This medicine may increase the risk of heart rhythm disturbances.
This medicine may increase the risk of seizures.
This medicine may cause drowsiness or reduced alertness.
Aripiprazole is an atypical antipsychotic used in the treatment of schizophrenia, bipolar disorder, and, in some cases, treatment-resistant major depression. It acts as a partial agonist of dopamine D2 and serotonin 5-HT1A receptors, as well as an antagonist of 5-HT2A receptors, helping to balance neurotransmitters in the brain.
Aripiprazole is available in tablet form, oral solutions, and long-acting injectable formulations. It is commonly used to reduce psychotic symptoms such as hallucinations and delusions and to stabilize mood in affective disorders.
Common side effects include nausea, dizziness, insomnia, and weight gain. In rare cases, severe adverse reactions such as neuroleptic malignant syndrome or tardive dyskinesia may occur.
Aripiprazole is an essential medication for managing psychiatric disorders, helping to improve patients' quality of life by reducing symptoms and preventing relapses.